{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:29:46Z","timestamp":1792016986983,"version":"4.4.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T00:00:00Z","timestamp":1718064000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T00:00:00Z","timestamp":1718064000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-024-02857-z","type":"journal-article","created":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T19:03:05Z","timestamp":1718132585000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Formulation Development and Evaluation of Cannabidiol Hot-Melt Extruded Solid Self-Emulsifying Drug Delivery System for Oral Applications"],"prefix":"10.1208","volume":"25","author":[{"given":"Kavish","family":"Sanil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Almotairy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prateek","family":"Uttreja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9013-1327","authenticated-orcid":false,"given":"Eman A.","family":"Ashour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,11]]},"reference":[{"issue":"4","key":"2857_CR1","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1007\/s40429-022-00438-3","volume":"9","author":"JH Khalsa","year":"2022","unstructured":"Khalsa JH, Bunt G, Blum K, Maggirwar SB, Galanter M, Potenza MN. Review: cannabinoids as medicinals. Curr Addict Rep. 2022;9(4):630\u201346.","journal-title":"Curr Addict Rep"},{"issue":"3","key":"2857_CR2","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s40263-021-00807-y","volume":"35","author":"S Lattanzi","year":"2021","unstructured":"Lattanzi S, Trinka E, Striano P, Rocchi C, Salvemini S, Silvestrini M, et al. Highly purified Cannabidiol for epilepsy treatment: a systematic review of epileptic conditions beyond Dravet syndrome and Lennox-Gastaut syndrome. CNS Drugs. 2021;35(3):265\u201381.","journal-title":"CNS Drugs"},{"issue":"7","key":"2857_CR3","doi-asserted-by":"publisher","first-page":"3680","DOI":"10.3390\/ijms22073680","volume":"22","author":"C Pagano","year":"2021","unstructured":"Pagano C, Navarra G, Coppola L, Bifulco M, Laezza C. Molecular mechanism of cannabinoids in cancer progression. Int J Mol Sci. 2021;22(7):3680.","journal-title":"Int J Mol Sci"},{"issue":"13","key":"2857_CR4","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1007\/s40265-021-01579-x","volume":"81","author":"B Stella","year":"2021","unstructured":"Stella B, Baratta F, Pepa CD, Arpicco S, Gastaldi D, Dosio F. Cannabinoid formulations and delivery systems: current and future options to treat pain. Drugs. 2021;81(13):1513\u201357.","journal-title":"Drugs"},{"issue":"8","key":"2857_CR5","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1002\/cbdv.200790150","volume":"4","author":"EB Russo","year":"2007","unstructured":"Russo EB, Guy GW, Robson PJ. Cannabis, pain, and sleep: lessons from therapeutic clinical trials of Sativex \u00ae, a cannabis-based medicine. Chem Biodivers. 2007;4(8):1729\u201343.","journal-title":"Chem Biodivers"},{"key":"2857_CR6","doi-asserted-by":"crossref","unstructured":"Millar SA, Maguire RF, Yates AS, O\u2019Sullivan SE. Towards better delivery of cannabidiol (CBD). Pharmaceuticals. 2020;28;13(9):219.","DOI":"10.3390\/ph13090219"},{"issue":"3\u20134","key":"2857_CR7","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1159\/000521683","volume":"107","author":"CA Legare","year":"2022","unstructured":"Legare CA, Raup-Konsavage WM, Vrana KE. Therapeutic potential of cannabis, Cannabidiol, and cannabinoid-based pharmaceuticals. Pharmacology. 2022;107(3\u20134):131\u201349.","journal-title":"Pharmacology"},{"issue":"7","key":"2857_CR8","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1002\/phar.1780","volume":"36","author":"PS Fasinu","year":"2016","unstructured":"Fasinu PS, Phillips S, ElSohly MA, Walker LA. Current status and prospects for Cannabidiol preparations as new therapeutic agents. Pharmacotherapy. 2016;36(7):781\u201396.","journal-title":"Pharmacotherapy"},{"issue":"13","key":"2857_CR9","doi-asserted-by":"publisher","first-page":"906038","DOI":"10.3389\/fphar.2022.906038","volume":"27","author":"A Salehi","year":"2022","unstructured":"Salehi A, Puchalski K, Shokoohinia Y, Zolfaghari B, Asgary S. Differentiating cannabis products: drugs, food, and supplements. Front Pharmacol. 2022;27(13):906038.","journal-title":"Front Pharmacol"},{"issue":"19","key":"2857_CR10","doi-asserted-by":"publisher","first-page":"14514","DOI":"10.3390\/ijms241914514","volume":"24","author":"KR Hossain","year":"2023","unstructured":"Hossain KR, Alghalayini A, Valenzuela SM. Current challenges and opportunities for improved Cannabidiol solubility. Int J Mol Sci. 2023;24(19):14514.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"2857_CR11","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/S0009-9236(96)90208-8","volume":"60","author":"ET Hellriegel","year":"1996","unstructured":"Hellriegel ET, Bjornsson TD, Hauck WW. Interpatient variability in bioavailability is related to the extent of absorption: Implications for bioavailability and bioequivalence studies. Clin Pharmacol Ther. 1996;60(6):601\u20137.","journal-title":"Clin Pharmacol Ther"},{"issue":"11","key":"2857_CR12","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/1359-6446(96)10039-8","volume":"1","author":"O Helen Chan","year":"1996","unstructured":"Helen Chan O, Stewart BH. Physicochemical and drug-delivery considerations for oral drug bioavailability. Drug Discovery Today. 1996;1(11):461\u201373.","journal-title":"Drug Discovery Today"},{"issue":"9","key":"2857_CR13","doi-asserted-by":"publisher","first-page":"661","DOI":"10.2165\/00003088-200241090-00003","volume":"41","author":"H Zhang","year":"2002","unstructured":"Zhang H, Zhang J, Streisand JB. Oral mucosal drug delivery: clinical pharmacokinetics and therapeutic applications. Clin Pharmacokinet. 2002;41(9):661\u201380.","journal-title":"Clin Pharmacokinet"},{"key":"2857_CR14","first-page":"2","volume":"1","author":"Y Krishnaiah","year":"2010","unstructured":"Krishnaiah Y. Pharmaceutical technologies for enhancing oral bioavailability of poorly soluble drugs. J Bioequivalence Bioavailab. 2010;1:2.","journal-title":"J Bioequivalence Bioavailab"},{"key":"2857_CR15","doi-asserted-by":"crossref","unstructured":"Alqahtani MS, Kazi M, Alsenaidy MA, Ahmad MZ. Advances in Oral Drug Delivery. Frontiers in Pharmacology [Internet]. 2021 [cited 2024 Feb 23];12. Available from: https:\/\/www.frontiersin.org\/journals\/pharmacology\/articles\/10.3389\/fphar.2021.618411.","DOI":"10.3389\/fphar.2021.618411"},{"issue":"3","key":"2857_CR16","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3390\/pharmaceutics11030129","volume":"11","author":"B Homayun","year":"2019","unstructured":"Homayun B, Lin X, Choi HJ. Challenges and recent progress in oral drug delivery systems for biopharmaceuticals. Pharmaceutics. 2019;11(3):129.","journal-title":"Pharmaceutics"},{"issue":"2","key":"2857_CR17","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3390\/bioengineering8020030","volume":"8","author":"H Aldewachi","year":"2021","unstructured":"Aldewachi H, Al-Zidan RN, Conner MT, Salman MM. High-throughput screening platforms in the discovery of novel drugs for neurodegenerative diseases. Bioengineering. 2021;8(2):30.","journal-title":"Bioengineering"},{"key":"2857_CR18","doi-asserted-by":"crossref","unstructured":"Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings.\u00a0Adv Drug Deliv Rev. 1997;15;23(1\u20133):3\u201325.","DOI":"10.1016\/S0169-409X(96)00423-1"},{"issue":"6","key":"2857_CR19","first-page":"57","volume":"1","author":"C Giliyar","year":"2006","unstructured":"Giliyar C, Fikstad DT, Tyavanagimatt S. Challenges and opportunities in oral delivery of poorly water-soluble drugs. Drug Deliv Technol. 2006;1(6):57\u201363.","journal-title":"Drug Deliv Technol"},{"issue":"6","key":"2857_CR20","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.apsb.2013.10.001","volume":"3","author":"S Kalepu","year":"2013","unstructured":"Kalepu S, Manthina M, Padavala V. Oral lipid-based drug delivery systems \u2013 an overview. Acta Pharmaceutica Sinica B. 2013;3(6):361\u201372.","journal-title":"Acta Pharmaceutica Sinica B"},{"issue":"6","key":"2857_CR21","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.addr.2007.10.015","volume":"60","author":"SS Rane","year":"2008","unstructured":"Rane SS, Anderson BD. What determines drug solubility in lipid vehicles: Is it predictable? Adv Drug Deliv Rev. 2008;60(6):638\u201356.","journal-title":"Adv Drug Deliv Rev"},{"key":"2857_CR22","unstructured":"Lipid \u2013 An emerging platform for oral delivery of drugs with poor bioavailability - ScienceDirect [Internet]. [cited 2023 Mar 28]. Available from: https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S0939641109001660."},{"issue":"3","key":"2857_CR23","doi-asserted-by":"publisher","first-page":"327","DOI":"10.3390\/pharmaceutics13030327","volume":"13","author":"C Cimino","year":"2021","unstructured":"Cimino C, Maurel OM, Musumeci T, Bonaccorso A, Drago F, Souto EMB, et al. Essential oils: pharmaceutical applications and encapsulation strategies into lipid-based delivery systems. Pharmaceutics. 2021;13(3):327.","journal-title":"Pharmaceutics"},{"issue":"4","key":"2857_CR24","doi-asserted-by":"publisher","first-page":"289","DOI":"10.2174\/2211738510666220817124744","volume":"10","author":"KC Panigrahi","year":"2022","unstructured":"Panigrahi KC, Patra CN, Rao MEB, Jena GK, Sahoo L. SEDDS basic design and recent formulation advancement: a concurrent review. PNT. 2022;10(4):289\u201398.","journal-title":"PNT"},{"key":"2857_CR25","unstructured":"Production, properties, and applications of solid self-emulsifying delivery systems (S-SEDS) in the food and pharmaceutical industries - ScienceDirect [Internet]. [cited 2023 Mar 23]. Available from: https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S0927775717309767?via%3Dihub."},{"key":"2857_CR26","doi-asserted-by":"crossref","unstructured":"Morozowich W, Gao P. Chapter 19 - Improving the Oral Absorption of Poorly Soluble Drugs Using SEDDS and S-SEDDS Formulations. In: Qiu Y, Chen Y, Zhang GGZ, Liu L, Porter WR, editors. Developing Solid Oral Dosage Forms [Internet]. San Diego: Academic Press; 2009 [cited 2023 Mar 24]. p. 443\u201368. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/B9780444532428000199.","DOI":"10.1016\/B978-0-444-53242-8.00019-9"},{"issue":"1","key":"2857_CR27","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0939-6411(00)00089-8","volume":"50","author":"T Gershanik","year":"2000","unstructured":"Gershanik T, Benita S. Self-dispersing lipid formulations for improving oral absorption of lipophilic drugs. Eur J Pharm Biopharm. 2000;50(1):179\u201388.","journal-title":"Eur J Pharm Biopharm"},{"issue":"8","key":"2857_CR28","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1111\/jphp.12077","volume":"65","author":"D Prasad","year":"2013","unstructured":"Prasad D, Chauhan H, Atef E. Studying the effect of lipid chain length on the precipitation of a poorly water soluble drug from self-emulsifying drug delivery system on dispersion into aqueous medium. J Pharm Pharmacol. 2013;65(8):1134\u201344.","journal-title":"J Pharm Pharmacol"},{"issue":"142","key":"2857_CR29","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.addr.2018.10.014","volume":"1","author":"I Nardin","year":"2019","unstructured":"Nardin I, K\u00f6llner S. Successful development of oral SEDDS: screening of excipients from the industrial point of view. Adv Drug Deliv Rev. 2019;1(142):128\u201340.","journal-title":"Adv Drug Deliv Rev"},{"issue":"4","key":"2857_CR30","doi-asserted-by":"publisher","first-page":"427","DOI":"10.2478\/acph-2013-0040","volume":"63","author":"K \u010cerpnjak","year":"2013","unstructured":"\u010cerpnjak K, Zvonar A, Ga\u0161perlin M, Vre\u010der F. Lipid-based systems as a promising approach for enhancing the bioavailability of poorly water-soluble drugs. Acta Pharm. 2013;63(4):427\u201345.","journal-title":"Acta Pharm"},{"key":"2857_CR31","unstructured":"Solubilization by Nonionic Surfactants in the HLB-Temperature Range | SpringerLink [Internet]. [cited 2023 Mar 24]. Available from: https:\/\/link.springer.com\/chapter\/10.1007\/978-1-4613-4157-4_25."},{"key":"2857_CR32","doi-asserted-by":"crossref","unstructured":"Pharmaceutics | Free Full-Text | Current Status of Supersaturable Self-Emulsifying Drug Delivery Systems [Internet]. [cited 2023 Mar 23]. Available from: https:\/\/www.mdpi.com\/1999-4923\/12\/4\/365.","DOI":"10.3390\/pharmaceutics12040365"},{"issue":"6","key":"2857_CR33","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.addr.2007.09.006","volume":"60","author":"V Jannin","year":"2008","unstructured":"Jannin V, Musakhanian J, Marchaud D. Approaches for the development of solid and semi-solid lipid-based formulations. Adv Drug Deliv Rev. 2008;60(6):734\u201346.","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"2857_CR34","first-page":"101","volume":"5","author":"MP Wagh","year":"2014","unstructured":"Wagh MP, Singh PK, Chaudhari CS, Khairnar DA. Solid self-emulsifying drug delivery system: Preparation techniques and dosage forms. Int J Biopharm. 2014;5(2):101\u20138.","journal-title":"Int J Biopharm."},{"issue":"84","key":"2857_CR35","doi-asserted-by":"publisher","first-page":"104558","DOI":"10.1016\/j.jddst.2023.104558","volume":"1","author":"I Karnik","year":"2023","unstructured":"Karnik I, Youssef AAA, Joshi P, Munnangi SR, Narala S, Varner C, et al. Formulation development and characterization of dual drug loaded hot-melt extruded inserts for better ocular therapeutic outcomes: Sulfacetamide\/prednisolone. J Drug Deliv Sci Technol. 2023;1(84):104558.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"8","key":"2857_CR36","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1111\/jphp.12579","volume":"68","author":"EA Ashour","year":"2016","unstructured":"Ashour EA, Majumdar S, Alsheteli A, Alshehri S, Alsulays B, Feng X, et al. Hot melt extrusion as an approach to improve solubility, permeability and oral absorption of a psychoactive natural product, piperine. J Pharm Pharmacol. 2016;68(8):989\u201398.","journal-title":"J Pharm Pharmacol"},{"issue":"576","key":"2857_CR37","doi-asserted-by":"publisher","first-page":"118989","DOI":"10.1016\/j.ijpharm.2019.118989","volume":"25","author":"R Thakkar","year":"2020","unstructured":"Thakkar R, Thakkar R, Pillai A, Ashour EA, Repka MA. Systematic screening of pharmaceutical polymers for hot melt extrusion processing: a comprehensive review. Int J Pharm. 2020;25(576):118989.","journal-title":"Int J Pharm"},{"issue":"6","key":"2857_CR38","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1080\/17425247.2019.1614912","volume":"16","author":"S Sarabu","year":"2019","unstructured":"Sarabu S, Bandari S, Kallakunta VR, Tiwari R, Patil H, Repka MA. An update on the contribution of hot-melt extrusion technology to novel drug delivery in the twenty-first century: part II. Expert Opin Drug Deliv. 2019;16(6):567\u201382.","journal-title":"Expert Opin Drug Deliv"},{"key":"2857_CR39","unstructured":"Islam MT. Implementing process analytical technology (PAT) tools for the analysis and control of manufacturing processes during hot-melt extrusion [Internet] [phd]. University of Greenwich; 2014 [cited 2024 Feb 23]. Available from: https:\/\/gala.gre.ac.uk\/id\/eprint\/23526\/."},{"issue":"641","key":"2857_CR40","doi-asserted-by":"publisher","first-page":"123055","DOI":"10.1016\/j.ijpharm.2023.123055","volume":"25","author":"V Raman Kallakunta","year":"2023","unstructured":"Raman Kallakunta V, Dudhipala N, Nyavanandi D, Sarabu S, YadavJanga K, Ajjarapu S, et al. Formulation and processing of solid self-emulsifying drug delivery systems (HME S-SEDDS): A single-step manufacturing process via hot-melt extrusion technology through response surface methodology. Int J Pharm. 2023;25(641):123055.","journal-title":"Int J Pharm"},{"issue":"3","key":"2857_CR41","doi-asserted-by":"publisher","first-page":"324","DOI":"10.3390\/pharmaceutics16030324","volume":"16","author":"P Uttreja","year":"2024","unstructured":"Uttreja P, Youssef AAA, Karnik I, Sanil K, Narala N, Wang H, et al. Formulation development of solid self-nanoemulsifying drug delivery systems of quetiapine fumarate via hot-melt extrusion technology: optimization using central composite design. Pharmaceutics. 2024;16(3):324.","journal-title":"Pharmaceutics"},{"key":"2857_CR42","doi-asserted-by":"crossref","unstructured":"Meena AK, Sharma K, Kandaswamy MU, Rajagopal S, Mullangi R. Formulation development of an albendazole self-emulsifying drug delivery system (SEDDS) with enhanced systemic exposure. Acta Pharmaceutica. 2012;31;62(4):563\u201380.","DOI":"10.2478\/v10007-012-0031-0"},{"issue":"1","key":"2857_CR43","first-page":"2733","volume":"8","author":"AA Khan","year":"2013","unstructured":"Khan AA, Mudassir J, Mohtar N, Darwis Y. Advanced drug delivery to the lymphatic system: lipid-based nanoformulations. IJN. 2013;8(1):2733\u201344.","journal-title":"IJN"},{"issue":"2","key":"2857_CR44","doi-asserted-by":"publisher","first-page":"244","DOI":"10.3390\/ph17020244","volume":"17","author":"SE O\u2019Sullivan","year":"2024","unstructured":"O\u2019Sullivan SE, Jensen SS, Kolli AR, Nikolajsen GN, Bruun HZ, Hoeng J. Strategies to improve cannabidiol bioavailability and drug delivery. Pharmaceuticals. 2024;17(2):244.","journal-title":"Pharmaceuticals"},{"issue":"2","key":"2857_CR45","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.colsurfb.2007.03.002","volume":"58","author":"H Yuan","year":"2007","unstructured":"Yuan H, Chen J, Du YZ, Hu FQ, Zeng S, Zhao HL. Studies on oral absorption of stearic acid SLN by a novel fluorometric method. Colloids Surf B Biointerfaces. 2007;58(2):157\u201364.","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"19","key":"2857_CR46","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.fpsl.2018.12.005","volume":"1","author":"L Lin","year":"2019","unstructured":"Lin L, Gu Y, Cui H. Moringa oil\/chitosan nanoparticles embedded gelatin nanofibers for food packaging against Listeria monocytogenes and Staphylococcus aureus on cheese. Food Packag Shelf Life. 2019;1(19):86\u201393.","journal-title":"Food Packag Shelf Life"},{"issue":"9","key":"2857_CR47","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/j.jsps.2021.07.012","volume":"29","author":"RA Vlad","year":"2021","unstructured":"Vlad RA, Antonoaea P, Todoran N, Muntean DL, R\u00e9dai EM, Sila\u0219i OA, et al. Pharmacotechnical and analytical preformulation studies for cannabidiol orodispersible tablets. Saudi Pharm J. 2021;29(9):1029\u201342.","journal-title":"Saudi Pharm J"},{"issue":"159","key":"2857_CR48","doi-asserted-by":"publisher","first-page":"105698","DOI":"10.1016\/j.ejps.2020.105698","volume":"1","author":"AP Matarazzo","year":"2021","unstructured":"Matarazzo AP, Elisei LMS, Carvalho FC, Bonf\u00edlio R, Ruela ALM, Galdino G, et al. Mucoadhesive nanostructured lipid carriers as a cannabidiol nasal delivery system for the treatment of neuropathic pain. Eur J Pharm Sci. 2021;1(159):105698.","journal-title":"Eur J Pharm Sci"},{"issue":"4","key":"2857_CR49","doi-asserted-by":"publisher","first-page":"703","DOI":"10.3390\/pharmaceutics14040703","volume":"14","author":"T Moqejwa","year":"2022","unstructured":"Moqejwa T, Marimuthu T, Kondiah PPD, Choonara YE. Development of stable nano-sized transfersomes as a rectal colloid for enhanced delivery of cannabidiol. Pharmaceutics. 2022;14(4):703.","journal-title":"Pharmaceutics"},{"issue":"57","key":"2857_CR50","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.ejps.2013.08.024","volume":"16","author":"ES Kostewicz","year":"2014","unstructured":"Kostewicz ES, Abrahamsson B, Brewster M, Brouwers J, Butler J, Carlert S, et al. In vitro models for the prediction of in vivo performance of oral dosage forms. Eur J Pharm Sci. 2014;16(57):342\u201366.","journal-title":"Eur J Pharm Sci"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-024-02857-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-024-02857-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-024-02857-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T16:26:21Z","timestamp":1725380781000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-024-02857-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,11]]},"references-count":50,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,6]]}},"alternative-id":["2857"],"URL":"https:\/\/doi.org\/10.1208\/s12249-024-02857-z","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,11]]},"assertion":[{"value":"27 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"136"}}